Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2007 Jan;11(1):6-8.
doi: 10.1016/j.ccr.2006.12.008.

Tracking normalization of brain tumor vasculature by magnetic imaging and proangiogenic biomarkers

Affiliations
Review

Tracking normalization of brain tumor vasculature by magnetic imaging and proangiogenic biomarkers

Adília Hormigo et al. Cancer Cell. 2007 Jan.

Abstract

Clinical assessment of the response to antiangiogenic therapy has been cumbersome. A study in this issue of Cancer Cell demonstrates that a combination of magnetic resonance imaging (MRI) for quantification of normalized vessels with measurements of circulating levels of proangiogenic factors, including FGF2, SDF1, and viable circulating endothelial cells, provides an effective means to evaluate the response of recurrent glioblastoma to a prototypical pan-VEGF receptor tyrosine kinase inhibitor, AZD2171.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Assessment of Response to Antiangiogenic Therapy with AZD2171 by Utilizing MRI and Biomarkers
ZD2171 targets immature vessels, while favoring the emergence of normalized pericyte coated blood vessels. Recurrence of the tumor is associated with generation of dilated, large, and leaky blood vessels as well as plasma elevation of proangiogenic factors, including FGF2, SDF1, and CECs. Normalization of the blood vessels is associated with a decrease in post-contrast T1-weighted MRI signal (T1), T2-weighted (flair, T2), permeability (Ktrans), and recovery of white matter integrity as detected by white matter tractography (WM). The MRI photographs were adapted from Batchelor et al. (2007).

Comment on

References

    1. Batchelor TT, Sorensen AG, di Tomaso E, Zhang WT, Duda DG, Cohen KS, Kozak KR, Cahill DP, Chen PJ, Zhu M, et al. Cancer Cell. 2007;(this issue) - PMC - PubMed
    1. Cha S. Magn Reson Imaging Clin N Am. 2003;11:403–413. - PubMed
    1. Dennie J, Mandeville JB, Boxerman JL, Packard SD, Rosen BR, Weisskoff RM. Magn Reson Med. 1998;40:793–799. - PubMed
    1. Hegi ME, Diserens AC, Gorlia T, Hamou MF, de Tribolet N, Weller M, Kros JM, Hainfellner JA, Mason W, Mariani L, et al. N Engl J Med. 2005;352:997–1003. - PubMed
    1. Jain RK. Science. 2005;307:58–62. - PubMed

MeSH terms